HomeCompareFWTKX vs JNJ

FWTKX vs JNJ: Dividend Comparison 2026

FWTKX yields 5.34% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FWTKX wins by $8.4K in total portfolio value
10 years
FWTKX
FWTKX
● Live price
5.34%
Share price
$17.61
Annual div
$0.94
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.4K
Annual income
$751.79
Full FWTKX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FWTKX vs JNJ

📍 FWTKX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFWTKXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FWTKX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FWTKX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FWTKX
Annual income on $10K today (after 15% tax)
$454.20/yr
After 10yr DRIP, annual income (after tax)
$639.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $64.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FWTKX + JNJ for your $10,000?

FWTKX: 50%JNJ: 50%
100% JNJ50/50100% FWTKX
Portfolio after 10yr
$24.2K
Annual income
$789.78/yr
Blended yield
3.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FWTKX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FWTKX buys
0
JNJ buys
0
No recent congressional trades found for FWTKX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFWTKXJNJ
Forward yield5.34%3.36%
Annual dividend / share$0.94$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.4K$20.0K
Annual income after 10y$751.79$827.78
Total dividends collected$6.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FWTKX vs JNJ ($10,000, DRIP)

YearFWTKX PortfolioFWTKX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,234$534.36$10,676$355.77+$558.00FWTKX
2$12,582$561.04$11,407$389.39+$1.2KFWTKX
3$14,050$587.23$12,198$426.53+$1.9KFWTKX
4$15,646$612.84$13,056$467.62+$2.6KFWTKX
5$17,379$637.82$13,987$513.12+$3.4KFWTKX
6$19,258$662.12$14,998$563.56+$4.3KFWTKX
7$21,292$685.70$16,098$619.52+$5.2KFWTKX
8$23,490$708.52$17,295$681.69+$6.2KFWTKX
9$25,865$730.55$18,599$750.82+$7.3KFWTKX
10$28,428$751.79$20,022$827.78+$8.4KFWTKX

FWTKX vs JNJ: Complete Analysis 2026

FWTKXStock

The fund invests in a combination of Fidelity ® U.S. equity funds, international equity funds, bond funds, and short-term funds. The adviser allocates its assets according to a neutral asset allocation strategy shown in the glide path below that adjusts over time until it reaches an allocation similar to that of the Fidelity Freedom ® Income Fund, approximately 10 to 19 years after the year 2035.

Full FWTKX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FWTKX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FWTKX vs SCHDFWTKX vs JEPIFWTKX vs OFWTKX vs KOFWTKX vs MAINFWTKX vs ABBVFWTKX vs MRKFWTKX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.